BRÈVE

sur Moderna, Inc. (NASDAQ:MRNA)

Moderna Recognized as Top Employer for Tenth Consecutive Year

Graphique de l'évolution du cours de l'action Moderna, Inc. (EBR:MRNA).

Moderna, Inc. has been named a top employer in the global biopharmaceutical sector by Science and Science Careers' 2024 Top Employers Survey. This marks the tenth consecutive year that Moderna receives this accolade. The company's commitment to innovation, respect for employees, and social responsibility were cited as key factors in this recognition.

CEO Stéphane Bancel highlighted Moderna's focus on a digital-first, inclusive work environment. In 2024, the company collaborated with OpenAI to implement ChatGPT Enterprise, enhancing operational efficiency. Moderna also centralized its workforce at a new global headquarters in Cambridge, Massachusetts, and continued manufacturing expansion in Marlborough.

Chief Human Resources Officer Tracey Franklin emphasized the company's unwavering dedication to excellence and maintaining a workplace where curiosity and purpose are prioritized. The survey included over 6,400 respondents, primarily from biotechnology, biopharmaceutical, and pharmaceutical sectors worldwide.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Moderna, Inc.